Are you Dr. Saukkonen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1400 Vfw Pkwy
# GB-138
West Roxbury, MA 02132Phone+1 857-203-6427Fax+1 857-203-5670
Summary
- Dr. Jussi Saukkonen, MD is a pulmonologist in West Roxbury, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Veterans Affairs Boston Healthcare System and Boston Medical Center.
Education & Training
- Boston University Medical CenterFellowship, Allergy and Immunology, 1998 - 2002
- Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1993
- University of MichiganInternship, Internal Medicine, 1985 - 1986
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1985
Certifications & Licensure
- MA State Medical License 1990 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB Start of enrollment: 2009 Apr 01
- Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- Establishing the safety of phenobarbital treatment of alcohol withdrawal syndrome on general medical wards: A retrospective cohort study.Matthew V Ronan, Rahul B Ganatra, Jussi Saukkonen
Alcohol. 2024-05-01 - 7 citationsCommunity-acquired Pneumonia Guideline Recommendations-Impact of a Consensus-based Process versus Systematic Reviews.Kevin C. Wilson, Noah C. Schoenberg, David L. Cohn, Kristina Crothers, Kevin P. Fennelly
Clinical Infectious Diseases. 2021-10-05 - Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimenKimberley N Chapman Hedges, Andrey S. Borisov, Jussi J. Saukkonen, Nigel A. Scott, Emily J. Hecker
Clinical Trials. 2020-02-01